@prefix : <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix core: <http://purl.obolibrary.org/obo/uberon/core#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix pato: <http://purl.obolibrary.org/obo/pato#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix core1: <http://purl.obolibrary.org/obo/core#> .
@prefix terms: <http://purl.org/dc/terms/> .
@prefix uberon: <http://purl.obolibrary.org/obo/uberon#> .
@prefix subsets: <http://purl.obolibrary.org/obo/ro/subsets#> .
@prefix oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix OpenPVSignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl#> .
@base <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions> .

<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions> rdf:type owl:Ontology ;
                                                                       owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                   mp: ;
                                                                       rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/255513/"^^xsd:anyURI ;
                                                                       rdfs:label "Finasteride and Convulsions"^^xsd:Literal ;
                                                                       owl:versionInfo "draft-v0.95-20211112"@en .

#################################################################
#    Annotation properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code
OpenPVSignal:has_ATC_code rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code
OpenPVSignal:has_ICD_code rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code
OpenPVSignal:has_MedDRA_code rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term
OpenPVSignal:has_MedDRA_prefered_term rdf:type owl:AnnotationProperty .


###  http://purl.org/dc/elements/1.1/publisher
dc:publisher rdf:type owl:AnnotationProperty .


###  http://purl.org/dc/terms/hasVersion
terms:hasVersion rdf:type owl:AnnotationProperty .


###  http://www.w3.org/2004/02/skos/core#exactMatch
skos:exactMatch rdf:type owl:AnnotationProperty .


###  http://www.w3.org/2004/02/skos/core#inScheme
skos:inScheme rdf:type owl:AnnotationProperty .


###  http://www.w3.org/2004/02/skos/core#notation
skos:notation rdf:type owl:AnnotationProperty .


#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
OpenPVSignal:Free_text_reporting_element rdf:type owl:ObjectProperty .


###  http://purl.org/mp/publishedBy
mp:publishedBy rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


#################################################################
#    Data properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count
OpenPVSignal:has_count rdfs:subPropertyOf owl:topDataProperty .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Case26
:Case26 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Case_Report_Information ;
        OpenPVSignal:has_content "two patients were reported to never have had a history of seizures " ;
        rdfs:label "Case 26 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#DiscussionAndConclusion
:DiscussionAndConclusion rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Conclusion ,
                                  OpenPVSignal:Discussion ;
                         mp:references :ref15 ,
                                       :ref16 ,
                                       :ref17 ,
                                       :ref18 ;
                         OpenPVSignal:has_content """Discussion and Conclusion
The original case report narratives describe patients who either had a history or predisposition to seizures (case 1, 4, 6, and 13), who had epilepsy that was well controlled on anti-epileptic therapy (case 5) or who had a regular pattern of seizures (case 12 and 24) but deve-loped convulsions after taking finasteride. Additionally, patients who were adherent to anti- epileptic therapy (case 7, 27 and 33) developed more seizures after their first within a few months of starting finasteride. One patient reported to have had his first seizure after one year of treatment with finasteride, but the seizures occurred at shorter intervals thereafter and resolved upon discontinuation of the medicine (case 30). One case (case 25) had a negative dechallenge: the patient continued to take finasteride despite the onset of three separate seizure episodes and did not recover after dis-continuing the drug. Finally, case 3 involves an alcoholic patient who had one hypoglycaemic seizure and recovered after glucose infusion.
The enzyme 5a-reductase is involved in the production of the endogenous neurosteroids 5a- THDOC (from deoxycorticosterone)
,allopregnanolone (from progesterone) and androstanediol (from testosterone). Recent studies on mice have shown that these endogenous neurosteroids may reduce seizure susceptibility by enhancing the inhibitory effects of GABA on GABAA receptors.
Hence, neurosteroids act as allosteric modulators of GABAA, similar to barbiturates or benzodiazepines.16 Inhibition of 5a-reductase by finasteride, with consequent reduction in the production of endogenous neurosteroids, may increase the potential for seizure activity.
Permanently lowering the seizure threshold in rats and subsequently administering finasteride in dose ranges compatible with humans, resulted in the development of seizures.15 Relatively long times to seizure onset have been explained by the time it takes for existing neurosteroids to be broken down.17
The convulsogenic potential of finasteride has yet to be demonstrated in humans, but the impact of finasteride on neurosteroid formation may interfere with the regulation of seizures in susceptible individuals. Finasteride crosses the blood-brain barrier so it has the potential to reduce neurosteroid synthesis in the brain, through inhibition of 5a-reductase: in patients who exhibit seizure susceptibility, this might be enough to further lower seizure threshold and trigger convulsions. Additionally, progesterone acts as an anticonvulsant, while testosterone has pro-convulsant properties. An excess of testosterone brought about by finasteride treatment (through inhibition of the enzyme that converts it to 5a-DHT) results in a higher concentration of 17P-estradiol, a potent pro- convulsant hormone.18 Despite the presence of alternative explanations in many of the reported cases, including predisposition to seizures and non-adherence to anticonvulsant medications, the plausible mechanism described above
 
strengthens the signal that finasteride may cause increased seizure activity, particularly in susceptible patients with a history of seizures.

""" ;
                         rdfs:label "Discussion and conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose1
:Dose1 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :finasteride ;
       OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 5 ;
       OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
       OpenPVSignal:refers_to_dose_value "5 mg" ;
       rdfs:label "Dose 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose10
:Dose10 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose11
:Dose11 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose12
:Dose12 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose13
:Dose13 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose14
:Dose14 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 14" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose15
:Dose15 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 15" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose16
:Dose16 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose17
:Dose17 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose18
:Dose18 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose19
:Dose19 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 19" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose2
:Dose2 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :finasteride ;
       OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 5 ;
       OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
       OpenPVSignal:refers_to_dose_value "5 mg" ;
       rdfs:label "Dose 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose21
:Dose21 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 21" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose22
:Dose22 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 22" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose23
:Dose23 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose24
:Dose24 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose25
:Dose25 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 25" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose26
:Dose26 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dechallenge_process "false"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 26" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose27
:Dose27 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dechallenge_process "false"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 27" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose28
:Dose28 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 28" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose29
:Dose29 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 5 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "5 mg" ;
        rdfs:label "Dose 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose3
:Dose3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :finasteride ;
       OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 5 ;
       OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
       OpenPVSignal:refers_to_dose_value "5 mg" ;
       rdfs:label "Dose 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose30
:Dose30 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose31
:Dose31 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 0.5 ,
                               1 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "0.5 mg" ,
                                          "1 mg" ;
        rdfs:label "Dose 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose32
:Dose32 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 32" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose33
:Dose33 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose34
:Dose34 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Dosage ;
        OpenPVSignal:refers_to_drug :finasteride ;
        OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
        OpenPVSignal:has_value 1 ;
        OpenPVSignal:refers_to_dose_value "1 mg" ;
        rdfs:label "Dose 34" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose4
:Dose4 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :finasteride ;
       OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 5 ;
       OpenPVSignal:refers_to_dose_value "5 mg" ;
       rdfs:label "Dose 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose6
:Dose6 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :finasteride ;
       OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 5 ;
       OpenPVSignal:refers_to_dose_value "5 mg" ;
       rdfs:label "Dose 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose7
:Dose7 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :finasteride ;
       OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 1 ;
       OpenPVSignal:refers_to_dechallenge_process "true"^^xsd:boolean ;
       OpenPVSignal:refers_to_dose_value "1 mg" ;
       rdfs:label "Dose 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Dose9
:Dose9 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Dosage ;
       OpenPVSignal:refers_to_drug :finasteride ;
       OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
       OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
       OpenPVSignal:has_value 1 ;
       OpenPVSignal:refers_to_dose_value "1 mg" ;
       rdfs:label "Dose 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#IntroductionContent
:IntroductionContent rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Introduction ;
                     mp:references :ref1 ,
                                   :ref2 ,
                                   :ref3 ,
                                   :ref4 ,
                                   :ref5 ;
                     OpenPVSignal:has_content """Introduction
Finasteride is a 5a-reductase inhibitor that received approval from the FDA in 1992. It is marketed by Merck Sharp & Dohme as Proscar (5 mg) and Propecia (1 mg), and is also available under several generic names. The higher dose regimen is intended for the treatment of benign prostatic hyperplasia (BPH) and hirsutism, while the lower dose regimen is intended for the management of androgenic alopecia. Each of these conditions is associated with elevated levels of the potent testosterone metabolite dihydrotestosterone (DHT). 5a- reductase is the enzyme responsible for converting testosterone to DHT; finasteride acts by inhibiting this enzyme, particulary the a-R2 and a-R3 isoforms. Finasteride was also found to reduce the incidence of low grade prostate cancer but concerns about a possible increased incidence of high grade prostate cancer among patients on finasteride has precluded its role in preventive therapy; a recent follow-up of a placebo-controlled study of finasteride for the prevention of prostate cancer showed no significant between-group difference in the rates of overall survival or survival after the diagnosis of prostate cancer.
An epileptic seizure is defined as a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain.

Seizures can be generalized and concerning activity in both hemispheres; or partial, concerning a localized group of neurons. Partial seizures can further be defined as complex if consciousness is altered during an episode and simple if they do not affect memory and awareness. Seizures that can be attributed to an agent or underlying condition are considered symptomatic; seizures for which no underlying factor can be identified are considered unprovoked and attributable to epilepsy.
Symptomatic seizures can be induced by a multitude of factors including: stroke, head injury, anoxia, hypoglycaemia, infections, fever, menstruation, drugs and non-adherence to antiepileptic drugs. The incidence of acute symptomatic seizures is 29-39 per 100 000 per
year, while the incidence of single unprovoked seizures is 23-61 per 100,000 person-years.4
The incidence of drug-induced seizures is difficult to determine.5 Although numerous drugs
can induce a convulsive state or lower the seizure threshold, the most common classes of drug are central acting agents, anti-diabetics, sympathomimetics and anti-asthmatics.
The term 'convulsions' in WHO-ART covers all seizure types, including absence seizures, partial seizures (simple and complex), tonic seizures, convulsions and epilepsy. The term 'convulsions grand mal' includes terms such as tonic-clonic convulsions, epilepsy grand mal and status epilepticus. Due to differences in coding, 10 ICSRs that were originally reported as 'convulsions' has been mapped to 'convulsions grand mal', these cases are marked with an asterisk in Table 1.
Introduction
Finasteride is a 5a-reductase inhibitor that received approval from the FDA in 1992. It is marketed by Merck Sharp & Dohme as Proscar (5 mg) and Propecia (1 mg), and is also available under several generic names. The higher dose regimen is intended for the treatment of benign prostatic hyperplasia (BPH) and hirsutism, while the lower dose regimen is intended for the management of androgenic alopecia. Each of these conditions is associated with elevated levels of the potent testosterone metabolite dihydrotestosterone (DHT). 5a- reductase is the enzyme responsible for converting testosterone to DHT; finasteride acts by inhibiting this enzyme, particulary the a-R2 and a-R3 isoforms. Finasteride was also found to reduce the incidence of low grade prostate cancer but concerns about a possible increased incidence of high grade prostate cancer among patients on finasteride has precluded its role in preventive therapy; a recent follow-up of a placebo-controlled study of finasteride for the prevention of prostate cancer showed no significant between-group difference in the rates of overall survival or survival after the diagnosis of prostate cancer.
An epileptic seizure is defined as a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain.

Seizures can be generalized and concerning activity in both hemispheres; or partial, concerning a localized group of neurons. Partial seizures can further be defined as complex if consciousness is altered during an episode and simple if they do not affect memory and awareness. Seizures that can be attributed to an agent or underlying condition are considered symptomatic; seizures for which no underlying factor can be identified are considered unprovoked and attributable to epilepsy.
Symptomatic seizures can be induced by a multitude of factors including: stroke, head injury, anoxia, hypoglycaemia, infections, fever, menstruation, drugs and non-adherence to antiepileptic drugs. The incidence of acute symptomatic seizures is 29-39 per 100 000 per
year, while the incidence of single unprovoked seizures is 23-61 per 100,000 person-years.4
The incidence of drug-induced seizures is difficult to determine.5 Although numerous drugs
can induce a convulsive state or lower the seizure threshold, the most common classes of drug are central acting agents, anti-diabetics, sympathomimetics and anti-asthmatics.
The term 'convulsions' in WHO-ART covers all seizure types, including absence seizures, partial seizures (simple and complex), tonic seizures, convulsions and epilepsy. The term 'convulsions grand mal' includes terms such as tonic-clonic convulsions, epilepsy grand mal and status epilepticus. Due to differences in coding, 10 ICSRs that were originally reported as 'convulsions' has been mapped to 'convulsions grand mal', these cases are marked with an asterisk in Table 1.
""" ;
                     rdfs:label "Introduction content" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#LiteratureAndLabelling
:LiteratureAndLabelling rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Literature_information ;
                        mp:references :ref8 ;
                        OpenPVSignal:has_content """Literature and Labelling
As of February 2014, there are two literature cases involving finasteride and seizures. One of the case reports (which was also reported to VigiBase and appears as case 15 in Table 1 below) concerns a woman from Italy who developed focal seizures at the age of 43 years. Two years later the seizures intensified and carbamazepine 800 mg per day was initiated. The seizures were kept under control for one year, until one night she experienced a convulsive seizure and, despite therapeutic levels of carbamazepine, her seizures relapsed with a frequency of eight to 10 seizures per year. Lamotrigine (300 mg) was added to her treatment regimen but the seizures were not controlled. The patient had a history of mild hirsutism for which she was treated with finasteride from age 45 years. Following discontinuation of finasteride at age 50 years, the lamotrigine dose was gradually reduced and withdrawn, and the carbamazepine dose was reduced to 600 mg without further seizures.8

The second case describes a 34-year-old obese, woman with hirsutism who suffered from intractable complex partial and generalized seizures, managed with 400 mg carbamazepine per day. She was treated with progesterone and her general seizure profile improved for two years. However, seizure frequency and severity increased after the introduction of finasteride, even though carbamazepine levels were within therapeutic range. The patient's condition returned to baseline levels after finasteride was withdrawn.
There is no mention in the UK SPC or FDA label that finasteride could either induce seizures or lower seizure threshold.""" ;
                        rdfs:label "Literature and labelling" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#MechanismOfFinasteride
:MechanismOfFinasteride rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Mechanism ;
                        OpenPVSignal:has_content "Finasteride is a 5a-reductase inhibitor that received approval from the FDA in 1992. It is marketed by Merck Sharp & Dohme as Proscar (5 mg) and Propecia (1 mg), and is also available under several generic names. The higher dose regimen is intended for the treatment of benign prostatic hyperplasia (BPH) and hirsutism, while the lower dose regimen is intended for the management of androgenic alopecia. Each of these conditions is associated with elevated levels of the potent testosterone metabolite dihydrotestosterone (DHT). 5a-reductase is the enzyme responsible for converting testosterone to DHT; finasteride acts by inhibiting this enzyme, particulary the a-R2 and a-R3 isoforms." ;
                        rdfs:label "Mechanism of finasteride" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient1
:Patient1 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 56 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient10
:Patient10 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient11
:Patient11 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 48 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient12
:Patient12 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 31 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient13
:Patient13 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient14
:Patient14 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 24 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 14" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient15
:Patient15 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 45 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 15" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient16
:Patient16 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 49 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient17
:Patient17 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 79 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient18
:Patient18 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 73 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient19
:Patient19 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 19 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 19" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient2
:Patient2 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 72 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient20
:Patient20 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 50 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 20" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient21
:Patient21 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 22 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 21" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient22
:Patient22 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 79 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 22" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient23
:Patient23 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 67 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient24
:Patient24 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 25 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient25
:Patient25 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 47 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 25" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient26
:Patient26 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 26" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient27
:Patient27 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 84 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 27" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient28
:Patient28 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 22 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 28" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient29
:Patient29 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 80 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient3
:Patient3 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 79 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient30
:Patient30 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 39 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient31
:Patient31 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 23 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient32
:Patient32 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 53 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 32" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient33
:Patient33 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 22 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient34
:Patient34 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 23 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 34" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient4
:Patient4 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 57 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient5
:Patient5 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient6
:Patient6 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 75 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient7
:Patient7 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 31 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient8
:Patient8 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 61 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Patient9
:Patient9 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#PotentialMechanismOfFinasterideTriggeringconvulsions-theGABAAParadigm
:PotentialMechanismOfFinasterideTriggeringconvulsions-theGABAAParadigm rdf:type owl:NamedIndividual ,
                                                                                OpenPVSignal:Adverse_Effect_Mechanism ;
                                                                       OpenPVSignal:refers_to_adverse_effect :convulsions ;
                                                                       mp:references :ref15 ,
                                                                                     :ref16 ;
                                                                       OpenPVSignal:has_content "Finasteride crosses the blood-brain barrier so it has the potential to reduce neurosteroid synthesis in the brain, through inhibition of 5a-reductase: in patients who exhibit seizure susceptibility, this might be enough to further lower seizure threshold and trigger convulsions." ,
                                                                                                "The enzyme 5a-reductase is involved in the production of the endogenous neurosteroids 5a- THDOC (from deoxycorticosterone) ,allopregnanolone (from progesterone) and androstanediol (from testosterone). Recent studies on mice have shown that these endogenous neurosteroids may reduce seizure susceptibility by enhancing the inhibitory effects of GABA on GABAA receptors. Hence, neurosteroids act as allosteric modulators of GABAA, similar to barbiturates or benzodiazepines.16 Inhibition of 5a-reductase by finasteride, with consequent reduction in the production of endogenous neurosteroids, may increase the potential for seizure activity" ;
                                                                       rdfs:label "Potential mechanism of finasteride triggering convulsions-the GABAA paradigm" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report1
:Report1 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :convulsions ,
                                               :drugLevelDecreased ;
         OpenPVSignal:refers_to_concomitant_drug :gemfibrozil ;
         OpenPVSignal:refers_to_past_diagnosis :epilepsy ;
         OpenPVSignal:refers_to_patient :Patient1 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_1 ;
         OpenPVSignal:refers_to_secondary_suspect_drug :phenytoin ;
         OpenPVSignal:time_to_onset :onset1 ;
         OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report10
:Report10 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsions ,
                                                :depression ,
                                                :malaise ,
                                                :weightDecrease ;
          OpenPVSignal:refers_to_patient :Patient10 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_10 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report11
:Report11 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsions ,
                                                :faecesDiscoloured ;
          OpenPVSignal:refers_to_concomitant_drug :carisoprodol ,
                                                  :folicAcid ,
                                                  :gabapentin ,
                                                  :lamotrigine ,
                                                  :naproxen ,
                                                  :nizatidine ,
                                                  :phenytoin ,
                                                  :tetracycline ,
                                                  :warfarin ;
          OpenPVSignal:refers_to_patient :Patient11 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_11 ;
          OpenPVSignal:time_to_onset :onset11 ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report12
:Report12 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsions ;
          OpenPVSignal:refers_to_concomitant_drug :carbamazepine ,
                                                  :levetiracetam ;
          OpenPVSignal:refers_to_past_diagnosis :epilepsy ;
          OpenPVSignal:refers_to_patient :Patient12 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_12 ;
          OpenPVSignal:time_to_onset :onset12 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report13
:Report13 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsions ;
          OpenPVSignal:refers_to_past_diagnosis :epilepsy ;
          OpenPVSignal:refers_to_patient :Patient13 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_13 ;
          OpenPVSignal:time_to_onset :onset13 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report14
:Report14 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :boneDisorder ,
                                                :convulsions ,
                                                :depression ,
                                                :diarrhoea ,
                                                :hairDiscolouration ,
                                                :malaise ,
                                                :muscleAtrophy ,
                                                :muscleContractionsInvoluntary ,
                                                :neurologicDisorderNos ,
                                                :weightDecrease ;
          OpenPVSignal:refers_to_patient :Patient14 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_14 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          OpenPVSignal:refers_to_rechallenge_outcome "positive rechallenge - condition appeared again" ;
          rdfs:label "Report 14" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report15
:Report15 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_15_info ;
          OpenPVSignal:refers_to_adverse_effect :conditionAggravated ,
                                                :convulsions ;
          OpenPVSignal:refers_to_concomitant_drug :carbamazepine ,
                                                  :lamotrigine ;
          OpenPVSignal:refers_to_patient :Patient15 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_15 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 15" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report16
:Report16 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ,
                                                :withdrawalSyndrome ;
          OpenPVSignal:refers_to_concomitant_drug :terfenadine ;
          OpenPVSignal:refers_to_patient :Patient16 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_16 ;
          OpenPVSignal:time_to_onset :onset16 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report17
:Report17 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ,
                                                :erythemaMultiforme ;
          OpenPVSignal:refers_to_concomitant_drug :atenolol ,
                                                  :bendroflumethiazide ,
                                                  :glycerylTrinitrate ;
          OpenPVSignal:refers_to_patient :Patient17 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_17 ;
          OpenPVSignal:time_to_onset :onset17 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report18
:Report18 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_18_info ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_concomitant_drug :oxazepam ;
          OpenPVSignal:refers_to_patient :Patient18 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_18 ;
          OpenPVSignal:time_to_onset :onset18 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report19
:Report19 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_patient :Patient19 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_19 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 19" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report2
:Report2 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :confusion ,
                                               :convulsions ,
                                               :syncope ;
         OpenPVSignal:refers_to_patient :Patient2 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_2 ;
         OpenPVSignal:time_to_onset :onset2 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report20
:Report20 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_patient :Patient20 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 20" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report21
:Report21 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case21 ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_patient :Patient21 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_21 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 21" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report22
:Report22 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case22B ;
          OpenPVSignal:refers_to_adverse_effect :aggressiveReaction ,
                                                :avBlockComplete ,
                                                :bronchospasm ,
                                                :cellulitis ,
                                                :convulsionsGrandMal ,
                                                :purpura ;
          OpenPVSignal:refers_to_concomitant_drug :diltiazem ,
                                                  :labetalol ,
                                                  :tamsulosin ,
                                                  :terazosin ;
          OpenPVSignal:refers_to_patient :Patient22 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_22 ;
          OpenPVSignal:refers_to_secondary_suspect_drug :simvastatin ;
          OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 22" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report23
:Report23 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case23 ;
          OpenPVSignal:refers_to_adverse_effect :bite ,
                                                :cardiomegaly ,
                                                :cerebralIschaemia ,
                                                :confusion ,
                                                :convulsionsGrandMal ,
                                                :ecgAbnormalSpecific ,
                                                :eegAbnormal ,
                                                :stupor ;
          OpenPVSignal:refers_to_concomitant_drug :acetylsalicylicAcid ,
                                                  :atorvastatin ,
                                                  <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ergocalciferol/Ascorbicacid/folicacid/Thiaminehydrochloride/retinol/riboflavin/nicotiNicAcid> ;
          OpenPVSignal:refers_to_patient :Patient23 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_23 ;
          OpenPVSignal:refers_to_secondary_suspect_drug :tamsulosin ;
          OpenPVSignal:time_to_onset :onset23 ;
          OpenPVSignal:refers_to_outcome_after_action "recovery without drug withdrawal" ;
          rdfs:label "Report 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report24
:Report24 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_concomitant_drug :lamotrigine ,
                                                  :lorazepam ,
                                                  :topiramate ;
          OpenPVSignal:refers_to_past_diagnosis :epilepsy ;
          OpenPVSignal:refers_to_patient :Patient24 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_24 ;
          OpenPVSignal:time_to_onset :onset24 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report25
:Report25 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case25 ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_patient :Patient25 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_25 ;
          OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 25" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report26
:Report26 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :Case26 ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_patient :Patient26 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_26 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 26" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report27
:Report27 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_27_info ;
          OpenPVSignal:refers_to_adverse_effect :cerebralIschaemia ,
                                                :convulsionsGrandMal ,
                                                :fatality ;
          OpenPVSignal:refers_to_concomitant_drug :acetylsalicylicAcid ,
                                                  :allopurinol ,
                                                  :ascorbicAcid ,
                                                  :celecoxib ,
                                                  :doxazosin ,
                                                  :memantine ,
                                                  :prednisone ,
                                                  :quetiapine ,
                                                  :ranitidine ,
                                                  :sulfasalazine ,
                                                  <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#hydrochlorothiazide/Triamterene> ;
          OpenPVSignal:refers_to_patient :Patient27 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_27 ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 27" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report28
:Report28 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_patient :Patient28 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_28 ;
          OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 28" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report29
:Report29 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case29 ;
          OpenPVSignal:refers_to_adverse_effect :arrhythmia ,
                                                :convulsionsGrandMal ,
                                                :hypotension ,
                                                :medicationError ;
          OpenPVSignal:refers_to_concomitant_drug :acetylsalicylicAcid ,
                                                  :levothyroxine ;
          OpenPVSignal:refers_to_patient :Patient29 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_29 ;
          OpenPVSignal:time_to_onset :onset29 ;
          OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report3
:Report3 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :case3 ;
         OpenPVSignal:refers_to_adverse_effect :convulsions ,
                                               :hepatocellularDamage ,
                                               :hypoglycaemia ;
         OpenPVSignal:refers_to_concomitant_drug :digoxin ,
                                                 :docusate ,
                                                 :furosemide ,
                                                 :lisinopril ,
                                                 :propranolol ;
         OpenPVSignal:refers_to_patient :Patient3 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_3 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         OpenPVSignal:refers_to_rechallenge_outcome "negative rechallenge - condition not appeared" ;
         rdfs:label "Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report30
:Report30 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case30 ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ,
                                                :heartDisorder ,
                                                :muscleContractionsInvoluntary ;
          OpenPVSignal:refers_to_concomitant_drug :nebivolol ;
          OpenPVSignal:refers_to_patient :Patient30 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_30 ;
          OpenPVSignal:time_to_onset :onset30 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          OpenPVSignal:refers_to_rechallenge_outcome "positive rechallenge - condition appeared again" ;
          rdfs:label "Report 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report31
:Report31 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :agitation ,
                                                :anxiety ,
                                                :convulsionsGrandMal ,
                                                :follicleStimulatingHormoneDecreased ,
                                                :impotence ,
                                                :neurologicDisorderNos ,
                                                :psychosis ,
                                                :resistance ;
          OpenPVSignal:refers_to_patient :Patient31 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_31 ;
          OpenPVSignal:time_to_onset :onset31 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report32
:Report32 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :cognitiveDisorders ,
                                                :convulsionsGrandMal ,
                                                :impotence ,
                                                :neurologicDisorderNos ;
          OpenPVSignal:refers_to_patient :Patient32 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_32 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 32" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report33
:Report33 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
          OpenPVSignal:refers_to_patient :Patient33 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_33 ;
          OpenPVSignal:time_to_onset :onset33 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report34
:Report34 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :anxiety ,
                                                :backPain ,
                                                :convulsionsGrandMal ,
                                                :depression ,
                                                :hepatocellularDamage ,
                                                :libidoDecreased ,
                                                :migraine ,
                                                :sexualFunctionAbnormal ;
          OpenPVSignal:refers_to_concomitant_drug :carbamazepine ,
                                                  :felbamate ,
                                                  :lamotrigine ,
                                                  :phenytoin ,
                                                  :valproicAcid ;
          OpenPVSignal:refers_to_past_diagnosis :seizure_disorder ;
          OpenPVSignal:refers_to_patient :Patient34 ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_34 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 34" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report4
:Report4 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :convulsions ;
         OpenPVSignal:refers_to_concomitant_drug :beclometasone ,
                                                 :terbinafine ,
                                                 :terbutaline ;
         OpenPVSignal:refers_to_past_diagnosis :epilepsy ;
         OpenPVSignal:refers_to_patient :Patient4 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_4 ;
         OpenPVSignal:time_to_onset :onset4 ;
         OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
         rdfs:label "Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report5
:Report5 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :convulsions ,
                                               :drugInteraction ;
         OpenPVSignal:refers_to_concomitant_drug :phenytoin ;
         OpenPVSignal:refers_to_past_diagnosis :epilepsy ;
         OpenPVSignal:refers_to_patient :Patient5 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report6
:Report6 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :convulsions ;
         OpenPVSignal:refers_to_concomitant_drug :carbamazepine ,
                                                 :diltiazem ;
         OpenPVSignal:refers_to_patient :Patient6 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_6 ;
         OpenPVSignal:time_to_onset :onset6 ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report7
:Report7 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :convulsions ;
         OpenPVSignal:refers_to_patient :Patient7 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_7 ;
         OpenPVSignal:time_to_onset :onset7 ;
         OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report8
:Report8 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :convulsions ;
         OpenPVSignal:refers_to_concomitant_drug :minoxidil ;
         OpenPVSignal:refers_to_patient :Patient8 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Report9
:Report9 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :convulsions ,
                                               :drugInteraction ;
         OpenPVSignal:refers_to_patient :Patient9 ;
         OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
         OpenPVSignal:refers_to_reported_drug_usage :usage_for_report_9 ;
         OpenPVSignal:refers_to_secondary_suspect_drug <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#paracetamol/pseudoephedrine> ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ReportsFromCanada
:ReportsFromCanada rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Reports_group ;
                   OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                   OpenPVSignal:has_count 2 ;
                   OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Canada" ;
                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                   rdfs:label "Reports from Canada" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ReportsFromGermany
:ReportsFromGermany rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Reports_group ;
                    OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                    OpenPVSignal:has_count 2 ;
                    OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Germany" ;
                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                    rdfs:label "Reports from Germany" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ReportsFromItaly
:ReportsFromItaly rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Reports_group ;
                  OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                  OpenPVSignal:has_count 1 ;
                  OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Italy" ;
                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                  rdfs:label "Reports from Italy" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ReportsFromUK
:ReportsFromUK rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Reports_group ;
               OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
               OpenPVSignal:has_count 4 ;
               OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_Kingdom" ;
               OpenPVSignal:refers_to_database "WHO Vigibase" ;
               rdfs:label "Reports from UK" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ReportsFromUS
:ReportsFromUS rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Reports_group ;
               OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
               OpenPVSignal:has_count 25 ;
               OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_States" ;
               OpenPVSignal:refers_to_database "WHO Vigibase" ;
               rdfs:label "Reports from US" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ReportsInVigibase
:ReportsInVigibase rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Free_text_reporting_element ;
                   OpenPVSignal:has_content """Reports in VigiBase
As of 3 December 2013, the WHO Global Individual Case Safety Report (ICSR) Database, VigiBase, unknown outcomes, two recovered and one did not.contained 28 ICSRs of 'convulsions' and another 24 ICSRs of 'convulsions grand mal' in association with finasteride. After the removal of duplicates, 15 distinct ICSRs were identified for the preferred term 'convulsions' and 19 ICSRs for 'convulsions grand mal', yielding a total of 34 cases. The ICSRs for both combinations had been submitted to VigiBase from five countries: US (25), UK (4), Canada (2), Germany (2) and Italy (1). All patients but one were male and age, where reported, ranged from 19 to 84 years (median age 49 years).
Finasteride was considered the only suspected drug in 30 cases; in one case the drug was reported as interacting, and in 15 cases it was the only reported drug. Co-suspected drugs were reported in four ICSRs (case 1, 9, 22 and
23) and are listed along with concomitant drugs in Table 1. Concomitant drugs for which the UK SPC and the FDA label list 'convulsions' or 'seizures' are included in three cases (case 11, 12 and 24), all of which are indicated for epilepsy. The dose of 5 mg was reported 14 times, 1 mg was reported 16 times, in one instance the reported dose was 0.5 mg to 1 mg, while in three cases the dose was not reported. Time to onset was reported in 17 of the 34 cases and ranged from six days to two years (median time to onset two months). Epilepsy had previously been diagnosed in six of 34 patients (case 1, 4, 5, 12, 13 and 24), seizure disorder in one (case 34, also non compliant to valproate), and two patients were reported to never have had a history of seizures (case 22 and 26). Two patients (case 3  alcoholic, and 21), were found to have high levels of alcohol when the event occurred, and one patient accidentally took two doses of finasteride instead of one (case 29). Two patients (case 22 and 23) suffered from small vessel or white matter ischemia, and in two further cases (case 18 and
27) the reporter attributed the reaction to benzodiazepine withdrawal or stroke. Finally, in three cases (case 2, 8 and 17) the EEG was regular despite the onset of seizures.
There were eight positive dechallenges, two of which were followed by positive rechallenge and one by negative rechallenge. One patient had a negative dechallenge. In eight cases the drug was withdrawn: the outcome was reported as unknown in five cases and recovered in three. Another three patients chose not to change their dosage or interrupt treatment: the outcome was unknown in one case, recovered in another and not recovered in the remaining case. Finally, dechallenge or rechallenge actions were not reported in 14 cases: eleven of these cases had unknown outcomes, two recovered and one did not.""" ;
                   rdfs:label "Reports in vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#SummaryContent
:SummaryContent rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Summary ;
                OpenPVSignal:has_content "Finasteride is used for the treatment of benign prostatic hyperplasia (BPH), male androgenic baldness and female hirsutism, and has been studied in the prevention of prostatic carcinoma. It acts as a competitive inhibitor of the 5a- reductase enzyme family, which is responsible for converting testosterone to dihydrotestosterone (DHT), a hormone that is present in higher concentrations in the conditions for which it is used. The WHO Global Individual Case Safety Report (ICSR) Database, VigiBase, contains 34 ICSRs with the WHO- ART terms 'convulsions' and 'convulsions grand mal' in association with finasteride. Inhibition of the production of endogenous neurosteroids, which modulate the GABAA receptor and reduce neuronal excitability, provides a plausible explanation for a causal association between finasteride and convulsions/ convulsions grand mal. The association is also coherent with the current biological understanding of epilepsy and with experimental animal data, and is consistent with the drug's pharmacokinetic profile." ;
                rdfs:label "Summary content" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#Uppsala_Monitoring_Centre
:Uppsala_Monitoring_Centre rdf:type owl:NamedIndividual ,
                                    prov:Organization ;
                           rdfs:label "Uppsala Monitoring Centre" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#acetylsalicylicAcid
:acetylsalicylicAcid rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "A01AD05" ,
                                               "B01AC06" ,
                                               "B01AC56" ,
                                               "C10BX01" ,
                                               "C10BX02" ,
                                               "C10BX04" ,
                                               "C10BX05" ,
                                               "C10BX06" ,
                                               "C10BX08" ,
                                               "M01BA03" ,
                                               "N02BA01" ,
                                               "N02BA51" ,
                                               "N02BA71" ;
                     rdfs:label "acetylsalicylic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#aggressiveReaction
:aggressiveReaction rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10001493 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Aggressive reaction" ;
                    rdfs:label "aggressive reaction" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#agitation
:agitation rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R45.1" ;
           OpenPVSignal:has_MedDRA_code 10001497 ;
           OpenPVSignal:has_MedDRA_prefered_term "Agitation" ;
           rdfs:label "Agitation" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#allopurinol
:allopurinol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "M04AA01" ,
                                       "M04AA51" ;
             rdfs:label "allopurinol" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#alopecia
:alopecia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Indication ;
          OpenPVSignal:has_ICD_code "L659" ;
          OpenPVSignal:has_MedDRA_code 10001760 ;
          OpenPVSignal:has_MedDRA_prefered_term "Alopecia" ;
          rdfs:label "alopecia" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#anoxia
:anoxia rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_MedDRA_code 10002660 ;
        OpenPVSignal:has_MedDRA_prefered_term "Anoxia" ;
        rdfs:label "anoxia" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#antiasthmatics
:antiasthmatics rdf:type owl:NamedIndividual ,
                         OpenPVSignal:DrugClass ;
                OpenPVSignal:has_ATC_code "R03" ;
                rdfs:label "antiasthmatics" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#antidiabetics
:antidiabetics rdf:type owl:NamedIndividual ,
                        OpenPVSignal:DrugClass ;
               OpenPVSignal:has_ATC_code "A10" ;
               rdfs:label "antidiabetics" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#anxiety
:anxiety rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_MedDRA_code 10002855 ;
         OpenPVSignal:has_MedDRA_prefered_term "Anxiety" ;
         rdfs:label "anxiety" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#arrhythmia
:arrhythmia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_MedDRA_code 10003119 ;
            OpenPVSignal:has_MedDRA_prefered_term "Arrhythmia" ;
            rdfs:label "arrhythmia" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ascorbicAcid
:ascorbicAcid rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "G01AD03" ,
                                        "S01XA15" ;
              rdfs:label "ascorbic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#atenolol
:atenolol rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "C07AB03" ,
                                    "C07BB03" ,
                                    "C07CB03" ,
                                    "C07CB53" ,
                                    "C07DB01" ,
                                    "C07FB03" ;
          rdfs:label "atenolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#atorvastatin
:atorvastatin rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "C10AA05" ,
                                        "C10BA05" ,
                                        "C10BX03" ,
                                        "C10BX06" ,
                                        "C10BX08" ,
                                        "C10BX11" ;
              rdfs:label "atorvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#avBlockComplete
:avBlockComplete rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_MedDRA_code 10003673 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Atrioventricular block complete" ;
                 rdfs:label "av block complete" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#backPain
:backPain rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_MedDRA_code 10003988 ;
          OpenPVSignal:has_MedDRA_prefered_term "Back pain" ;
          rdfs:label "back pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#beclometasone
:beclometasone rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "A07EA07" ,
                                         "D07AC15" ,
                                         "R01AD01" ,
                                         "R03BA01" ;
               rdfs:label "beclometasone" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#bendroflumethiazide
:bendroflumethiazide rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "C03AA01" ,
                                               "C03AB01" ,
                                               "C03EA13" ,
                                               "G01AE10" ;
                     rdfs:label "bendroflumethiazide" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#benignProstaticHyperplasia
:benignProstaticHyperplasia rdf:type owl:NamedIndividual ,
                                     OpenPVSignal:Indication ;
                            OpenPVSignal:has_ICD_code "N40.1" ;
                            OpenPVSignal:has_MedDRA_code 10004446 ;
                            OpenPVSignal:has_MedDRA_prefered_term "Benign prostatic hyperplasia" ;
                            rdfs:label "benign prostatic hyperplasia" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#bite
:bite rdf:type owl:NamedIndividual ,
               OpenPVSignal:Adverse_Effect ;
      OpenPVSignal:has_MedDRA_code 10004966 ;
      OpenPVSignal:has_MedDRA_prefered_term "Bite" ;
      rdfs:label "bite" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#boneDisorder
:boneDisorder rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_MedDRA_code 10005956 ;
              OpenPVSignal:has_MedDRA_prefered_term "Bone disorder" ;
              rdfs:label "bone disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#bronchospasm
:bronchospasm rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_MedDRA_code 10006482 ;
              OpenPVSignal:has_MedDRA_prefered_term "Bronchospasm" ;
              rdfs:label "bronchospasm" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#carbamazepine
:carbamazepine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N03AF01" ;
               rdfs:label "carbamazepine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#cardiomegaly
:cardiomegaly rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_MedDRA_code 10007632 ;
              OpenPVSignal:has_MedDRA_prefered_term "Cardiomegaly" ;
              rdfs:label "cardiomegaly" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#carisoprodol
:carisoprodol rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "M03BA02" ,
                                        "M03BA52" ,
                                        "M03BA72" ;
              rdfs:label "carisoprodol" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case21
:case21 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Case_Report_Information ;
        OpenPVSignal:has_content "Two patients (case 3  alcoholic, and 21), were found to have high levels of alcohol when the event occurred" ;
        rdfs:label "case 21 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case22B
:case22B rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Case_Report_Information ;
         OpenPVSignal:has_content "suffered from small vessel or white matter ischemia" ,
                                  "two patients were reported to never have had a history of seizures" ;
         rdfs:label "case 22 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case23
:case23 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Case_Report_Information ;
        OpenPVSignal:has_content "suffered from small vessel or white matter ischemia" ;
        rdfs:label "case 23 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case25
:case25 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Case_Report_Information ;
        OpenPVSignal:has_content "One case (case 25) had a negative dechallenge: the patient continued to take finasteride despite the onset of three separate seizure episodes and did not recover after dis-continuing the drug. " ;
        rdfs:label "case 25 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case29
:case29 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Case_Report_Information ;
        OpenPVSignal:has_content "one patient accidentally took two doses of finasteride instead of one (case 29). " ;
        rdfs:label "case 29 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case3
:case3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Case_Report_Information ;
       OpenPVSignal:has_content "Two patients (case 3  alcoholic, and 21), were found to have high levels of alcohol when the event occurred" ,
                                "case 3 involves an alcoholic patient who had one hypoglycaemic seizure and recovered after glucose infusion." ;
       rdfs:label "case 3 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case30
:case30 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Case_Report_Information ;
        OpenPVSignal:has_content "One patient reported to have had his first seizure after one year of treatment with finasteride, but the seizures occurred at shorter intervals thereafter and resolved upon discontinuation of the medicine (case 30)" ;
        rdfs:label "case 30 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case_15_info
:case_15_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              mp:references :ref8 ;
              OpenPVSignal:has_content "One of the case reports (which was also reported to VigiBase and appears as case 15 in Table 1 below) concerns a woman from Italy who developed focal seizures at the age of 43 years. Two years later the seizures intensified and carbamazepine 800 mg per day was initiated. The seizures were kept under control for one year, until one night she experienced a convulsive seizure and, despite therapeutic levels of carbamazepine, her seizures relapsed with a frequency of eight to 10 seizures per year. Lamotrigine (300 mg) was added to her treatment regimen but the seizures were not controlled. The patient had a history of mild hirsutism for which she was treated with finasteride from age 45 years. Following discontinuation of finasteride at age 50 years, the lamotrigine dose was gradually reduced and withdrawn, and the carbamazepine dose was reduced to 600 mg without further seizures.8" ;
              rdfs:label "case 15 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case_18_info
:case_18_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "the reporter attributed the reaction to benzodiazepine withdrawal or stroke" ;
              rdfs:label "case 18 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#case_27_info
:case_27_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "the reporter attributed the reaction to benzodiazepine withdrawal or stroke" ;
              rdfs:label "case 27 info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#celecoxib
:celecoxib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "G01AE10" ,
                                     "L01XX33" ,
                                     "M01AH01" ;
           rdfs:label "celecoxib" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#cellulitis
:cellulitis rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_MedDRA_code 10007882 ;
            OpenPVSignal:has_MedDRA_prefered_term "Cellulitis" ;
            rdfs:label "cellulitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#central_acting_agents
:central_acting_agents rdf:type owl:NamedIndividual ,
                                OpenPVSignal:DrugClass ;
                       OpenPVSignal:has_ATC_code "C02A" ;
                       rdfs:label "central acting agents" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#cerebralIschaemia
:cerebralIschaemia rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_MedDRA_code 10008120 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Cerebral ischaemia" ;
                   rdfs:label "cerebral ischaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#cognitiveDisorders
:cognitiveDisorders rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10057668 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Cognitive disorder" ;
                    rdfs:label "cognitive disorders" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#conditionAggravated
:conditionAggravated rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10010264 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Condition aggravated" ;
                     rdfs:label "condition aggravated" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#confusion
:confusion rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10010305 ;
           OpenPVSignal:has_MedDRA_prefered_term "Confusional state" ;
           rdfs:label "confusion" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#convulsions
:convulsions rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_MedDRA_code 10010904 ;
             OpenPVSignal:has_MedDRA_prefered_term "Convulsion" ;
             rdfs:label "convulsions" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#convulsionsGrandMal
:convulsionsGrandMal rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10018100 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Generalised tonic-clonic seizure" ;
                     rdfs:label "convulsions grand mal" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#depression
:depression rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_MedDRA_code 10012378 ;
            OpenPVSignal:has_MedDRA_prefered_term "Depression" ;
            rdfs:label "depression" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#diarrhoea
:diarrhoea rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10012735 ;
           OpenPVSignal:has_MedDRA_prefered_term "Diarrhoea" ;
           rdfs:label "diarrhoea" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#digoxin
:digoxin rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "C01AA05" ;
         rdfs:label "digoxin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#diltiazem
:diltiazem rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C05AE03" ,
                                     "C08DB01" ;
           rdfs:label "diltiazem" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#docusate
:docusate rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "A06AA02" ,
                                    "A06AG10" ;
          rdfs:label "docusate" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#doxazosin
:doxazosin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C02CA04" ;
           rdfs:label "doxazosin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#drugInteraction
:drugInteraction rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code 10013710 ;
                 OpenPVSignal:has_MedDRA_code 10013710 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Drug interaction" ;
                 rdfs:label "drug interaction" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#drugLevelDecreased
:drugLevelDecreased rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10013718 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Drug level decreased" ;
                    rdfs:label "drug level decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ecgAbnormalSpecific
:ecgAbnormalSpecific rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10014088 ;
                     OpenPVSignal:has_MedDRA_prefered_term "ECG abnormal specific" ;
                     rdfs:label "ecg abnormal specific" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#eegAbnormal
:eegAbnormal rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_MedDRA_code 10014408 ;
             OpenPVSignal:has_MedDRA_prefered_term "Electroencephalogram abnormal" ;
             rdfs:label "eeg abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#epilepsy
:epilepsy rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Past_Diagnosis ;
          OpenPVSignal:has_MedDRA_code 10015037 ;
          OpenPVSignal:has_MedDRA_prefered_term "Epilepsy" ;
          rdfs:label "epilepsy" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#erythemaMultiforme
:erythemaMultiforme rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10015218 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Erythema multiforme" ;
                    rdfs:label "erythema multiforme" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#faecesDiscoloured
:faecesDiscoloured rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_MedDRA_code 10016100 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Faeces discoloured" ;
                   rdfs:label "faeces discoloured" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#fatality
:fatality rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_MedDRA_code 10011906 ;
          OpenPVSignal:has_MedDRA_prefered_term "Death" ;
          rdfs:label "fatality" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#felbamate
:felbamate rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N03AX10" ;
           rdfs:label "felbamate" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#fever
:fever rdf:type owl:NamedIndividual ,
                OpenPVSignal:Adverse_Effect ;
       OpenPVSignal:has_MedDRA_code 10037660 ;
       OpenPVSignal:has_MedDRA_prefered_term "Pyrexia" ;
       rdfs:label "fever" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#finasteride
:finasteride rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_mechanism :MechanismOfFinasteride ,
                                        :PotentialMechanismOfFinasterideTriggeringconvulsions-theGABAAParadigm ,
                                        <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#PotentialMechanismOfFinasterideTriggeringconvulsions-thetestosterone/progesteroneParadigm> ;
             OpenPVSignal:has_ATC_code "G04CB01" ;
             rdfs:label "finasteride" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#finasteride_and_convulsions
:finasteride_and_convulsions rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Pharmacovigilance_Signal_Report ;
                             OpenPVSignal:refers_to_signal :pvSignal ;
                             mp:publishedBy :Uppsala_Monitoring_Centre ;
                             OpenPVSignal:has_creation_date "01/07/2014" ;
                             OpenPVSignal:has_overall_conclusion "causal association" ;
                             rdfs:label "finasteride and convulsions" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#finasteride_usage
:finasteride_usage rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Drug_Usage ;
                   OpenPVSignal:concerns_indication_for_use :alopecia ,
                                                            :benignProstaticHyperplasia ,
                                                            :hirsutism ,
                                                            :prostateCancer ;
                   OpenPVSignal:refers_to_dosage <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#1_mg_dose> ,
                                                 <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#5_mg_dose> ;
                   OpenPVSignal:refers_to_drug :finasteride ;
                   rdfs:label "finasteride usage" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#folicAcid
:folicAcid rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "B03AE01" ,
                                     "B03AE02" ,
                                     "B03BB01" ,
                                     "B03BB51" ;
           rdfs:label "folic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#follicleStimulatingHormoneDecreased
:follicleStimulatingHormoneDecreased rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Adverse_Effect ;
                                     OpenPVSignal:has_MedDRA_code 10005533 ;
                                     OpenPVSignal:has_MedDRA_prefered_term "Blood follicle stimulating hormone decreased" ;
                                     rdfs:label "follicle stimulating hormone decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#furosemide
:furosemide rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C03CA01" ,
                                      "C03CB01" ,
                                      "C03EB01" ,
                                      "G01AE10" ;
            rdfs:label "furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#gabapentin
:gabapentin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AX12" ;
            rdfs:label "gabapentin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#gemfibrozil
:gemfibrozil rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C10AB04" ;
             rdfs:label "gemfibrozil" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#glycerylTrinitrate
:glycerylTrinitrate rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug ;
                    OpenPVSignal:has_ATC_code "C01DA02" ,
                                              "C05AE01" ;
                    rdfs:label "glyceryl trinitrate " .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#hairDiscolouration
:hairDiscolouration rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10019036 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Hair discolouration" ;
                    rdfs:label "hair discolouration" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#headInjury
:headInjury rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_MedDRA_code 10019196 ;
            OpenPVSignal:has_MedDRA_prefered_term "Head injury" ;
            rdfs:label "head injury" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#heartDisorder
:heartDisorder rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_MedDRA_code 10061024 ;
               OpenPVSignal:has_MedDRA_prefered_term "Cardiac disorder" ;
               rdfs:label "heart disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#hepatocellularDamage
:hepatocellularDamage rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_MedDRA_code 10019837 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Hepatocellular injury" ;
                      rdfs:label "hepatocellular damage" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#hirsutism
:hirsutism rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Indication ;
           OpenPVSignal:has_ICD_code "L68.0" ;
           OpenPVSignal:has_MedDRA_code 10020112 ;
           OpenPVSignal:has_MedDRA_prefered_term "Hirsutism" ;
           rdfs:label "hirsutism" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#hypoglycaemia
:hypoglycaemia rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_MedDRA_code 10020993 ;
               OpenPVSignal:has_MedDRA_prefered_term "Hypoglycaemia" ;
               rdfs:label "hypoglycaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#hypotension
:hypotension rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_MedDRA_code 10021097 ;
             OpenPVSignal:has_MedDRA_prefered_term "Hypotension" ;
             rdfs:label "hypotension" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#impotence
:impotence rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10021550 ;
           OpenPVSignal:has_MedDRA_prefered_term "Impotence" ;
           rdfs:label "impotence" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#inVivoExperiments
:inVivoExperiments rdf:type owl:NamedIndividual ,
                            obo:OAE_0001197 ;
                   OpenPVSignal:refers_to_adverse_effect :convulsions ;
                   OpenPVSignal:refers_to_drug :finasteride ;
                   mp:references :ref15 ,
                                 :ref16 ,
                                 :ref17 ;
                   OpenPVSignal:has_content "The enzyme 5a-reductase is involved in the production of the endogenous neurosteroids 5a-THDOC (from deoxycorticosterone) ,allopregnanolone (from progesterone) and androstanediol (from testosterone). Recent studies on mice have shown that these endogenous neurosteroids may reduce seizure susceptibility by enhancing the inhibitory effects of GABA on GABAA receptors. Hence, neurosteroids act as allosteric modulators of GABAA, similar to barbiturates or benzodiazepines.16 Inhibition of 5a-reductase by finasteride, with consequent reduction in the production of endogenous neurosteroids, may increase the potential for seizure activity. Permanently lowering the seizure threshold in rats and subsequently administering finasteride in dose ranges compatible with humans, resulted in the development of seizures.15 Relatively long times to seizure onset have been explained by the time it takes for existing neurosteroids to be broken down.17" ;
                   rdfs:label "in vivo experiments" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#incidenceOfAcuteSymptomaticSeizures
:incidenceOfAcuteSymptomaticSeizures rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Incidence ;
                                     OpenPVSignal:refers_to_adverse_effect :seizure_disorder ;
                                     OpenPVSignal:has_content "29-39 per 100 000 per year" ;
                                     rdfs:label "incidence of acute symptomatic seizures" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#incidenceOfSingleUnprovokedSeizures
:incidenceOfSingleUnprovokedSeizures rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Incidence ;
                                     OpenPVSignal:refers_to_adverse_effect :seizure_disorder ;
                                     OpenPVSignal:has_content "23-61 per 100,000 person-years" ;
                                     rdfs:label "incidence of single unprovoked seizures" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#infections
:infections rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_MedDRA_code 10021789 ;
            OpenPVSignal:has_MedDRA_prefered_term "Infection" ;
            rdfs:label "infections" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#labetalol
:labetalol rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C07AG01" ,
                                     "C07BG01" ,
                                     "C07CG01" ;
           rdfs:label "labetalol" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#lamotrigine
:lamotrigine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N03AX09" ;
             rdfs:label "lamotrigine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#levetiracetam
:levetiracetam rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N03AX14" ;
               rdfs:label "levetiracetam" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#levothyroxine
:levothyroxine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "H03AA01" ;
               rdfs:label "levothyroxine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#libidoDecreased
:libidoDecreased rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_MedDRA_code 10024419 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Libido decreased" ;
                 rdfs:label "libido decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#lisinopril
:lisinopril rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C09AA03" ,
                                      "C09BA03" ,
                                      "C09BB03" ,
                                      "C10BX07" ;
            rdfs:label "lisinopril" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#literature_case
:literature_case rdf:type owl:NamedIndividual ,
                          obo:OAE_0001197 ;
                 OpenPVSignal:refers_to_adverse_effect :convulsions ;
                 OpenPVSignal:refers_to_drug :finasteride ;
                 OpenPVSignal:has_content "The second case describes a 34-year-old obese, woman with hirsutism who suffered from intractable complex partial and generalized seizures, managed with 400 mg carbamazepine per day. She was treated with progesterone and her general seizure profile improved for two years. However, seizure frequency and severity increased after the introduction of finasteride, even though carbamazepine levels were within therapeutic range. The patient's condition returned to baseline levels after finasteride was withdrawn." ;
                 rdfs:label "literature case" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#lorazepam
:lorazepam rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N05BA06" ,
                                     "N05BA56" ;
           rdfs:label "lorazepam" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#malaise
:malaise rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_MedDRA_code 10025482 ;
         OpenPVSignal:has_MedDRA_prefered_term "Malaise" ;
         rdfs:label "malaise" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#medicationError
:medicationError rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_MedDRA_code 10027091 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Medication error" ;
                 rdfs:label "medication error" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#memantine
:memantine rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N06DA52" ,
                                     "N06DA53" ,
                                     "N06DX01" ;
           rdfs:label "memantine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#menstruation
:menstruation rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_MedDRA_code 10070933 ;
              OpenPVSignal:has_MedDRA_prefered_term "Menstruation normal" ;
              rdfs:label "menstruation" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#migraine
:migraine rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_MedDRA_code 10027599 ;
          OpenPVSignal:has_MedDRA_prefered_term "Migraine" ;
          rdfs:label "migraine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#minoxidil
:minoxidil rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C02DC01" ,
                                     "D11AX01" ;
           rdfs:label "minoxidil" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#muscleAtrophy
:muscleAtrophy rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_MedDRA_code 10028289 ;
               OpenPVSignal:has_MedDRA_prefered_term "Muscle atrophy" ;
               rdfs:label "muscle atrophy" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#muscleContractionsInvoluntary
:muscleContractionsInvoluntary rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Adverse_Effect ;
                               OpenPVSignal:has_MedDRA_code 10028293 ;
                               OpenPVSignal:has_MedDRA_prefered_term "Muscle contractions involuntary" ;
                               rdfs:label "muscle contractions involuntary" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#naproxen
:naproxen rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "G02CC02" ,
                                    "M01AE02" ,
                                    "M01AE52" ,
                                    "M01AE56" ,
                                    "M02AA12" ;
          rdfs:label "naproxen" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#nebivolol
:nebivolol rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C07AB12" ,
                                     "C07BB12" ,
                                     "C07FB12" ;
           rdfs:label "nebivolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#neurologicDisorderNos
:neurologicDisorderNos rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_MedDRA_code 10029202 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Nervous system disorder" ;
                       rdfs:label "neurologic disorder nos" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#nizatidine
:nizatidine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A02BA04" ;
            rdfs:label "nizatidine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#one_day_interval
:one_day_interval rdf:type owl:NamedIndividual ,
                           <http://www.w3.org/2006/time#DurationDescription> ;
                  <http://www.w3.org/2006/time#nominalPosition> "days" ;
                  <http://www.w3.org/2006/time#numericPosition> 1 ;
                  rdfs:label "one day interval" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset1
:onset1 rdf:type owl:NamedIndividual ,
                 <http://www.w3.org/2006/time#DurationDescription> ;
        <http://www.w3.org/2006/time#nominalPosition> "days" ;
        <http://www.w3.org/2006/time#numericPosition> 26 ;
        rdfs:label "onset 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset11
:onset11 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         <http://www.w3.org/2006/time#nominalPosition> "days" ;
         <http://www.w3.org/2006/time#numericPosition> 9 ;
         rdfs:label "onset 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset12
:onset12 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         <http://www.w3.org/2006/time#nominalPosition> "days" ;
         <http://www.w3.org/2006/time#numericPosition> 14 ;
         rdfs:label "onset 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset13
:onset13 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         <http://www.w3.org/2006/time#nominalPosition> "months" ;
         <http://www.w3.org/2006/time#numericPosition> 6 ;
         rdfs:label "onset 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset16
:onset16 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         <http://www.w3.org/2006/time#nominalPosition> "days" ;
         <http://www.w3.org/2006/time#numericPosition> 170 ;
         rdfs:label "onset 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset17
:onset17 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         OpenPVSignal:has_content "27 days" ;
         <http://www.w3.org/2006/time#nominalPosition> "days" ;
         <http://www.w3.org/2006/time#numericPosition> 27 ;
         rdfs:label "onset 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset18
:onset18 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         <http://www.w3.org/2006/time#nominalPosition> "months" ;
         <http://www.w3.org/2006/time#numericPosition> 2 ;
         rdfs:label "onset 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset2
:onset2 rdf:type owl:NamedIndividual ,
                 <http://www.w3.org/2006/time#DurationDescription> ;
        <http://www.w3.org/2006/time#nominalPosition> "days" ;
        <http://www.w3.org/2006/time#numericPosition> 6 ;
        rdfs:label "onset 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset23
:onset23 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         OpenPVSignal:has_content "~2 years" ;
         <http://www.w3.org/2006/time#nominalPosition> "years" ;
         <http://www.w3.org/2006/time#numericPosition> 2 ;
         rdfs:label "onset 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset24
:onset24 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         OpenPVSignal:has_content "10 days" ;
         <http://www.w3.org/2006/time#nominalPosition> "days" ;
         <http://www.w3.org/2006/time#numericPosition> 10 ;
         rdfs:label "onset 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset29
:onset29 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         OpenPVSignal:has_content "~4 months" ;
         <http://www.w3.org/2006/time#nominalPosition> "months" ;
         <http://www.w3.org/2006/time#numericPosition> 4 ;
         rdfs:label "onset 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset30
:onset30 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         <http://www.w3.org/2006/time#nominalPosition> "years" ;
         <http://www.w3.org/2006/time#numericPosition> 1 ;
         rdfs:label "onset 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset31
:onset31 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         OpenPVSignal:has_content "~7 months" ;
         <http://www.w3.org/2006/time#nominalPosition> "months" ;
         <http://www.w3.org/2006/time#numericPosition> 7 ;
         rdfs:label "onset 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset33
:onset33 rdf:type owl:NamedIndividual ,
                  <http://www.w3.org/2006/time#DurationDescription> ;
         <http://www.w3.org/2006/time#nominalPosition> "months" ;
         <http://www.w3.org/2006/time#numericPosition> 4 ;
         rdfs:label "onset 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset4
:onset4 rdf:type owl:NamedIndividual ,
                 <http://www.w3.org/2006/time#DurationDescription> ;
        <http://www.w3.org/2006/time#nominalPosition> "days" ;
        <http://www.w3.org/2006/time#numericPosition> 264 ;
        rdfs:label "onset 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset6
:onset6 rdf:type owl:NamedIndividual ,
                 <http://www.w3.org/2006/time#DurationDescription> ;
        <http://www.w3.org/2006/time#nominalPosition> "days" ;
        <http://www.w3.org/2006/time#numericPosition> 24 ;
        rdfs:label "onset 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#onset7
:onset7 rdf:type owl:NamedIndividual ,
                 <http://www.w3.org/2006/time#DurationDescription> ;
        <http://www.w3.org/2006/time#nominalPosition> "months" ;
        <http://www.w3.org/2006/time#numericPosition> 2 ;
        rdfs:label "onset 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#oxazepam
:oxazepam rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N05BA04" ;
          rdfs:label "oxazepam" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#phenytoin
:phenytoin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N03AB02" ,
                                     "N03AB52" ;
           rdfs:label "phenytoin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#prednisone
:prednisone rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A07EA03" ,
                                      "H02AB07" ;
            rdfs:label "prednisone" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#propranolol
:propranolol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C07AA05" ,
                                       "C07BA05" ,
                                       "C07FA05" ;
             rdfs:label "propranolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#prostateCancer
:prostateCancer rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_MedDRA_code 10060862 ;
                OpenPVSignal:has_MedDRA_prefered_term "Prostate cancer" ;
                rdfs:label "prostate cancer" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#psychosis
:psychosis rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_MedDRA_code 10037234 ;
           OpenPVSignal:has_MedDRA_prefered_term "Psychosis" ;
           rdfs:label "psychosis" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#purpura
:purpura rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_MedDRA_code 10037549 ;
         OpenPVSignal:has_MedDRA_prefered_term "Purpura" ;
         rdfs:label "purpura" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Signal ;
          OpenPVSignal:Free_text_reporting_element :DiscussionAndConclusion ,
                                                   :IntroductionContent ,
                                                   :ReportsInVigibase ,
                                                   :SummaryContent ,
                                                   <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#convulsions/epilepticSeizuresPathobiology> ;
          OpenPVSignal:is_supported_by_individual_case_report :Report1 ,
                                                              :Report10 ,
                                                              :Report11 ,
                                                              :Report12 ,
                                                              :Report13 ,
                                                              :Report14 ,
                                                              :Report15 ,
                                                              :Report16 ,
                                                              :Report17 ,
                                                              :Report18 ,
                                                              :Report19 ,
                                                              :Report2 ,
                                                              :Report20 ,
                                                              :Report21 ,
                                                              :Report22 ,
                                                              :Report23 ,
                                                              :Report24 ,
                                                              :Report25 ,
                                                              :Report26 ,
                                                              :Report27 ,
                                                              :Report28 ,
                                                              :Report29 ,
                                                              :Report3 ,
                                                              :Report30 ,
                                                              :Report31 ,
                                                              :Report32 ,
                                                              :Report33 ,
                                                              :Report34 ,
                                                              :Report4 ,
                                                              :Report5 ,
                                                              :Report6 ,
                                                              :Report7 ,
                                                              :Report8 ,
                                                              :Report9 ;
          OpenPVSignal:is_supported_by_statistical_entity :ReportsFromCanada ,
                                                          :ReportsFromGermany ,
                                                          :ReportsFromItaly ,
                                                          :ReportsFromUK ,
                                                          :ReportsFromUS ,
                                                          :incidenceOfAcuteSymptomaticSeizures ,
                                                          :incidenceOfSingleUnprovokedSeizures ,
                                                          :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ,
                                                          :reportsForConvulsionsAndFinasteride ,
                                                          :reportsForConvulsionsGrandMalAndFinasteride ,
                                                          :reportsWithDrugWithdrawn ,
                                                          :reportsWithFinasterideBeingTheOnlyReportedDrug ,
                                                          :reportsWithFinasterideBeingTheOnlySuspectDrug ,
                                                          :reportsWithNegativeRechallenge ,
                                                          :reportsWithNoRecoveryAsOutcome ,
                                                          :reportsWithPositiveDechallenges ,
                                                          :reportsWithPositiveRechallenge ,
                                                          :reportsWithRecoveryAsOutcome ,
                                                          :reportsWithUnknownOutcome ,
                                                          :reportsWithco-suspectDrugs ,
                                                          :reportsWithoutWithdrawalOfTheDrug ,
                                                          :reports_with_5_mg_dose ,
                                                          :reports_with_dose_1_mg ,
                                                          :reports_with_drug_withdrawn_with_recovery ,
                                                          :reports_with_epilepsy_as_past_diagnosis ,
                                                          :reports_with_finasteride_being_interacting ,
                                                          :reports_with_negative_dechallenge ,
                                                          :reports_with_seizure_disorder_as_past_diagnosis ,
                                                          :reports_with_time_to_onset_info ,
                                                          :reports_without_withdrawal_of_the_drug_with_no_recovery ,
                                                          :reports_without_withdrawal_of_the_drug_with_recovery ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithConfounders_drugsThatAreUsedAgainstconvulsions/seizures> ;
          OpenPVSignal:refers_to_adverse_effect :convulsions ;
          OpenPVSignal:refers_to_drug :finasteride ;
          OpenPVSignal:refers_to_primary_suspect_drug :finasteride ;
          mp:supportedByData :inVivoExperiments ,
                             :literature_case ,
                             :seizures_and_inducing_drugs ,
                             :seizures_and_inducing_factors ;
          OpenPVSignal:initially_identified_on "01/07/2014" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#quetiapine
:quetiapine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N05AH04" ;
            rdfs:label "quetiapine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ranitidine
:ranitidine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A02BA02" ,
                                      "A02BA07" ;
            rdfs:label "ranitidine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref1
:ref1 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Thompson IM, Jr., Goodman PJ, Tangen CM, Parnes HL, Minasian LM, Godley PA, et al. Long-term survival of participants in the prostate cancer prevention trial. N Engl J Med. 2013;369:603-10." ;
      rdfs:label "ref1" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref10
:ref10 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "UK Summary of Product Characteristics for finaste-ride. URL: http://www.medicines. org.uk/emc/medicine/27492/SPC/Finasteride+5+mg+Tablets/ Accessed: 11 February 2014." ;
       rdfs:label "ref10" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref11
:ref11 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "US FDA product label for finasteride. URL: http://wwwaccessdata.fda.gov/drugsatfda_do cs/ label/2014/020788s024lbl.pdf Accessed: 11 February 2014" ;
       rdfs:label "ref11" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref12
:ref12 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Azzouni F, Godoy A, Li Y, Mohler J. The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol. 2012;2012:Article 530121." ;
       rdfs:label "ref12" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref13
:ref13 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Reddy DS. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res. 2009;85:1-30." ;
       rdfs:label "ref13" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref14
:ref14 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Duskova M, Hill M, Hanus M, Matouskova M, Starka L. Finasteride treatment and neuroactive steroid formation. Prague Med Rep. 2009;110:222-30." ;
       rdfs:label "ref14" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref15
:ref15 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE, et al. A new look at the 5a-reductase inhibitor finasteride. CNS Drug Rev 2006;12:53-76." ;
       rdfs:label "ref15" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref16
:ref16 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Hosie AM, Wilkins ME, Smart TG. Neurosteroid binding sites on GABA(A) receptors. Pharmacol Ther. 2007;116:7-19." ;
       rdfs:label "ref16" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref17
:ref17 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Lawrence C, Martin BS, Sun C, Williamson J, Kapur J. Endogenous neurosteroid synthesis modulates seizure frequency. Ann Neurol. 2010;67:689-93." ;
       rdfs:label "ref17" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref18
:ref18 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Reddy DS. Mass spectrometric assay and physiological-pharmacological activity of androgenic neurosteroids. Neurochem Int. 2008;52:54" ;
       rdfs:label "ref18" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref2
:ref2 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470-2." ;
      rdfs:label "ref2" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref3
:ref3 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "McNamara JO. Cellular and molecular basis of epilepsy. J Neurosci. 1994;14:3413-25." ;
      rdfs:label "ref3" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref4
:ref4 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Hauser WA, Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia 2008;49 Suppl 1:8-12." ;
      rdfs:label "ref4" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref5
:ref5 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Murphy K, Delanty N. Drug-induced seizures: general principles in assessment, management and prevention. CNS Drugs 2000;14:135-46." ;
      rdfs:label "ref5" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref6
:ref6 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content """Behnoush B, Taghadosinejad F, Arefi M, Shahabi M, Jamalian M, Kazemifar AM.Prevalence and complications of drug-induced seizures in Baharloo hospital, Tehran, Iran.
Iranian Jornal of Toxicology 2012;6:588-93.""" ;
      rdfs:label "ref6" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref7
:ref7 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Alldredge BK. Drug-induced seizures: controversies in their identification and management. Pharmacotherapy. 1997;17:857-60." ;
      rdfs:label "ref7" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref8
:ref8 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Pugnaghi M, Monti G, Biagini G, Meletti S. Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis. BMJ Case Rep. 2013;2013 February 19th." ;
      rdfs:label "ref8" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ref9
:ref9 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol. 2003;53:390-1." ;
      rdfs:label "ref9" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal
:reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal rdf:type owl:NamedIndividual ,
                                                                                         OpenPVSignal:Reports_group ;
                                                                                OpenPVSignal:has_count 34 ;
                                                                                OpenPVSignal:has_count_of_men 33 ;
                                                                                OpenPVSignal:has_count_of_women 1 ;
                                                                                OpenPVSignal:has_max_age "84.0"^^xsd:float ;
                                                                                OpenPVSignal:has_median_age "49.0"^^xsd:float ;
                                                                                OpenPVSignal:has_min_age "19.0"^^xsd:float ;
                                                                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                rdfs:label "overall reports for analysis without duplicates for the term convulsions and convulsions grand mal" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsForConvulsionsAndFinasteride
:reportsForConvulsionsAndFinasteride rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                     OpenPVSignal:refers_to_adverse_effect :convulsions ;
                                     OpenPVSignal:refers_to_drug :finasteride ;
                                     OpenPVSignal:has_count 15 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports for convulsions and finasteride" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsForConvulsionsGrandMalAndFinasteride
:reportsForConvulsionsGrandMalAndFinasteride rdf:type owl:NamedIndividual ,
                                                      OpenPVSignal:Reports_group ;
                                             OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                             OpenPVSignal:refers_to_adverse_effect :convulsionsGrandMal ;
                                             OpenPVSignal:refers_to_drug :finasteride ;
                                             OpenPVSignal:has_count 19 ;
                                             OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                             rdfs:label "reports for convulsions grand mal and finasteride" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithDrugWithdrawn
:reportsWithDrugWithdrawn rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                          OpenPVSignal:has_count 5 ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
                          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                          rdfs:label "reports with drug withdrawn with unknown outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithFinasterideBeingTheOnlyReportedDrug
:reportsWithFinasterideBeingTheOnlyReportedDrug rdf:type owl:NamedIndividual ,
                                                         OpenPVSignal:Reports_group ;
                                                OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                                OpenPVSignal:has_count 15 ;
                                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                rdfs:label "reports with finasteride being the only reported drug" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithFinasterideBeingTheOnlySuspectDrug
:reportsWithFinasterideBeingTheOnlySuspectDrug rdf:type owl:NamedIndividual ,
                                                        OpenPVSignal:Reports_group ;
                                               OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                               OpenPVSignal:has_count 30 ;
                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                               rdfs:label "reports with finasteride being the only suspect drug" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithNegativeRechallenge
:reportsWithNegativeRechallenge rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :reportsWithPositiveDechallenges ;
                                OpenPVSignal:has_count 1 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_rechallenge_outcome "negative rechallenge - condition not appeared" ;
                                rdfs:label "reports with negative rechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithNoRecoveryAsOutcome
:reportsWithNoRecoveryAsOutcome rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                OpenPVSignal:has_count 1 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                                rdfs:label "reports with no recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithPositiveDechallenges
:reportsWithPositiveDechallenges rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Reports_group ;
                                 OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                 OpenPVSignal:has_count 8 ;
                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                 OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
                                 rdfs:label "reports with positive dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithPositiveRechallenge
:reportsWithPositiveRechallenge rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :reportsWithPositiveDechallenges ;
                                OpenPVSignal:has_count 2 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_rechallenge_outcome "positive rechallenge - condition appeared again" ;
                                rdfs:label "reports with positive rechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithRecoveryAsOutcome
:reportsWithRecoveryAsOutcome rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Reports_group ;
                              OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                              OpenPVSignal:has_count 2 ;
                              OpenPVSignal:refers_to_database "WHO Vigibase" ;
                              OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                              rdfs:label "reports with recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithUnknownOutcome
:reportsWithUnknownOutcome rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Reports_group ;
                           OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                           OpenPVSignal:has_count 11 ;
                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                           OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                           rdfs:label "reports with unknown outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithco-suspectDrugs
:reportsWithco-suspectDrugs rdf:type owl:NamedIndividual ,
                                     OpenPVSignal:Reports_group ;
                            OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                            OpenPVSignal:has_count 4 ;
                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                            rdfs:label "reports with co-suspect drugs" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithoutWithdrawalOfTheDrug
:reportsWithoutWithdrawalOfTheDrug rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                   OpenPVSignal:has_count 1 ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   OpenPVSignal:refers_to_dechallenge_process "false"^^xsd:boolean ;
                                   OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                                   rdfs:label "reports without withdrawal of the drug with unknown outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_with_5_mg_dose
:reports_with_5_mg_dose rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Reports_group ;
                        OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                        OpenPVSignal:refers_to_dosage <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#5_mg_dose> ;
                        OpenPVSignal:has_count 14 ;
                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                        rdfs:label "reports with dose 5 mg" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_with_dose_1_mg
:reports_with_dose_1_mg rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Reports_group ;
                        OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                        OpenPVSignal:refers_to_dosage <http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#1_mg_dose> ;
                        OpenPVSignal:has_count 16 ;
                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                        rdfs:label "reports with dose 1 mg" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_with_drug_withdrawn_with_recovery
:reports_with_drug_withdrawn_with_recovery rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                           OpenPVSignal:has_count 3 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
                                           rdfs:label "reports with drug withdrawn with recovery" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_with_epilepsy_as_past_diagnosis
:reports_with_epilepsy_as_past_diagnosis rdf:type owl:NamedIndividual ,
                                                  OpenPVSignal:Reports_group ;
                                         OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                         OpenPVSignal:refers_to_past_diagnosis :epilepsy ;
                                         OpenPVSignal:has_count 6 ;
                                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                         rdfs:label "reports with epilepsy as past diagnosis" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_with_finasteride_being_interacting
:reports_with_finasteride_being_interacting rdf:type owl:NamedIndividual ,
                                                     OpenPVSignal:Reports_group ;
                                            OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                            OpenPVSignal:has_count 1 ;
                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                            rdfs:label "reports with finasteride being interacting" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_with_negative_dechallenge
:reports_with_negative_dechallenge rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                   OpenPVSignal:has_count 1 ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
                                   rdfs:label "reports with negative dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_with_seizure_disorder_as_past_diagnosis
:reports_with_seizure_disorder_as_past_diagnosis rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                                 OpenPVSignal:refers_to_past_diagnosis :seizure_disorder ;
                                                 OpenPVSignal:has_count 1 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports with seizure disorder as past diagnosis" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_with_time_to_onset_info
:reports_with_time_to_onset_info rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Reports_group ;
                                 OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                 OpenPVSignal:time_to_onset :time_to_onset_info ;
                                 OpenPVSignal:has_count 17 ;
                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                 rdfs:label "reports with time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_without_withdrawal_of_the_drug_with_no_recovery
:reports_without_withdrawal_of_the_drug_with_no_recovery rdf:type owl:NamedIndividual ,
                                                                  OpenPVSignal:Reports_group ;
                                                         OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                                         OpenPVSignal:has_count 1 ;
                                                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                         OpenPVSignal:refers_to_dechallenge_process "false"^^xsd:boolean ;
                                                         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                                                         rdfs:label "reports without withdrawal of the drug with no recovery" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reports_without_withdrawal_of_the_drug_with_recovery
:reports_without_withdrawal_of_the_drug_with_recovery rdf:type owl:NamedIndividual ,
                                                               OpenPVSignal:Reports_group ;
                                                      OpenPVSignal:is_subgroup_of :reportsForAnalysisWithoutDuplicatesForTheTermConvulsionsAndConvulsionsGrandMal ;
                                                      OpenPVSignal:has_count 1 ;
                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                      OpenPVSignal:refers_to_outcome_after_action "recovery without drug withdrawal" ;
                                                      rdfs:label "reports without withdrawal of the drug with recovery" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#resistance
:resistance rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            rdfs:label "resistance" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#seizure_disorder
:seizure_disorder rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ,
                           OpenPVSignal:Past_Diagnosis ;
                  OpenPVSignal:has_MedDRA_code 10039906 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Seizure" ;
                  rdfs:label "seizure disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#seizures_and_inducing_drugs
:seizures_and_inducing_drugs rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Warning_Information ;
                             OpenPVSignal:refers_to_adverse_effect :seizure_disorder ;
                             OpenPVSignal:refers_to_class :antiasthmatics ,
                                                          :antidiabetics ,
                                                          :central_acting_agents ,
                                                          :sympathomimetics ;
                             OpenPVSignal:has_content "Although numerous drugs can induce a convulsive state or lower the seizure threshold, the most common classes of drug are central acting agents, anti-diabetics, sympathomimetics and anti-asthmatics." ;
                             rdfs:label "seizures and inducing drugs" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#seizures_and_inducing_factors
:seizures_and_inducing_factors rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Warning_Information ;
                               OpenPVSignal:refers_to_adverse_effect :anoxia ,
                                                                     :fever ,
                                                                     :headInjury ,
                                                                     :hypoglycaemia ,
                                                                     :infections ,
                                                                     :menstruation ,
                                                                     :seizure_disorder ,
                                                                     :stroke ;
                               OpenPVSignal:has_content "Symptomatic seizures can be induced by a multitude of factors including: stroke, head injury, anoxia, hypoglycaemia, infections, fever, menstruation, drugs and non-adherence to antiepileptic drugs." ;
                               rdfs:label "seizures and inducing factors" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#sexualFunctionAbnormal
:sexualFunctionAbnormal rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_MedDRA_code 10040482 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Sexual function abnormal" ;
                        rdfs:label "sexual function abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#simvastatin
:simvastatin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "A10BH51" ,
                                       "C10AA01" ,
                                       "C10BA02" ,
                                       "C10BA04" ,
                                       "C10BX01" ,
                                       "C10BX04" ;
             rdfs:label "simvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#stroke
:stroke rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_MedDRA_code 10042244 ;
        OpenPVSignal:has_MedDRA_prefered_term "Stroke" ;
        rdfs:label "stroke" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#stupor
:stupor rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_MedDRA_code 10042264 ;
        OpenPVSignal:has_MedDRA_prefered_term "Stupor" ;
        rdfs:label "stupor" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#sulfasalazine
:sulfasalazine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "A07EC01" ,
                                         "G01AE10" ;
               rdfs:label "sulfasalazine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#sympathomimetics
:sympathomimetics rdf:type owl:NamedIndividual ,
                           OpenPVSignal:DrugClass ;
                  OpenPVSignal:has_ATC_code "N06BA" ;
                  rdfs:label "sympathomimetics" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#syncope
:syncope rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_MedDRA_code 10042772 ;
         OpenPVSignal:has_MedDRA_prefered_term "Syncope" ;
         rdfs:label "syncope" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#tamsulosin
:tamsulosin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "G04CA02" ,
                                      "G04CA52" ,
                                      "G04CA53" ;
            rdfs:label "tamsulosin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#terazosin
:terazosin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "G04CA03" ;
           rdfs:label "terazosin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#terbinafine
:terbinafine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "D01AE15" ,
                                       "D01BA02" ;
             rdfs:label "terbinafine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#terbutaline
:terbutaline rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "R03AC03" ,
                                       "R03CC03" ,
                                       "R03CC53" ;
             rdfs:label "terbutaline" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#terfenadine
:terfenadine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "R06AX12" ;
             rdfs:label "terfenadine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#tetracycline
:tetracycline rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A01AB13" ,
                                        "A02BD02" ,
                                        "A02BD08" ,
                                        "D06AA04" ,
                                        "J01AA07" ,
                                        "J01AA20" ,
                                        "J01RA08" ,
                                        "S01AA09" ,
                                        "S02AA08" ,
                                        "S03AA02" ;
              rdfs:label "tetracycline" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#time_to_onset_info
:time_to_onset_info rdf:type owl:NamedIndividual ,
                             <http://www.w3.org/2006/time#DurationDescription> ;
                    OpenPVSignal:has_content "Time to onset was reported in 17 of the 34 cases and ranged from six days to two years (median time to onset two months)." ;
                    rdfs:label "time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#topiramate
:topiramate rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AX11" ;
            rdfs:label "topiramate" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_1
:usage_for_report_1 rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug_Usage ;
                    OpenPVSignal:refers_to_dosage :Dose1 ;
                    OpenPVSignal:refers_to_drug :finasteride ;
                    rdfs:label "usage for report 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_10
:usage_for_report_10 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose10 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_11
:usage_for_report_11 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose11 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_12
:usage_for_report_12 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose12 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_13
:usage_for_report_13 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose13 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_14
:usage_for_report_14 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose14 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 14" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_15
:usage_for_report_15 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose15 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 15" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_16
:usage_for_report_16 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose16 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_17
:usage_for_report_17 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose17 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_18
:usage_for_report_18 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose18 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_19
:usage_for_report_19 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose19 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 19" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_2
:usage_for_report_2 rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug_Usage ;
                    OpenPVSignal:refers_to_dosage :Dose2 ;
                    OpenPVSignal:refers_to_drug :finasteride ;
                    rdfs:label "usage for report 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_21
:usage_for_report_21 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose21 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 21" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_22
:usage_for_report_22 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose22 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 22" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_23
:usage_for_report_23 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose23 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_24
:usage_for_report_24 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose24 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_25
:usage_for_report_25 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose25 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 25" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_26
:usage_for_report_26 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose26 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 26" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_27
:usage_for_report_27 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose27 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 27" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_28
:usage_for_report_28 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose28 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 28" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_29
:usage_for_report_29 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose29 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_3
:usage_for_report_3 rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug_Usage ;
                    OpenPVSignal:refers_to_dosage :Dose3 ;
                    OpenPVSignal:refers_to_drug :finasteride ;
                    rdfs:label "usage for report 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_30
:usage_for_report_30 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose30 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_31
:usage_for_report_31 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose31 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_32
:usage_for_report_32 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose32 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 32" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_33
:usage_for_report_33 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose33 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_34
:usage_for_report_34 rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Usage ;
                     OpenPVSignal:refers_to_dosage :Dose34 ;
                     OpenPVSignal:refers_to_drug :finasteride ;
                     rdfs:label "usage for report 34" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_4
:usage_for_report_4 rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug_Usage ;
                    OpenPVSignal:refers_to_dosage :Dose4 ;
                    OpenPVSignal:refers_to_drug :finasteride ;
                    rdfs:label "usage for report 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_6
:usage_for_report_6 rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug_Usage ;
                    OpenPVSignal:refers_to_dosage :Dose6 ;
                    OpenPVSignal:refers_to_drug :finasteride ;
                    rdfs:label "usage for report 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_7
:usage_for_report_7 rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug_Usage ;
                    OpenPVSignal:refers_to_dosage :Dose7 ;
                    OpenPVSignal:refers_to_drug :finasteride ;
                    rdfs:label "usage for report 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#usage_for_report_9
:usage_for_report_9 rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug_Usage ;
                    OpenPVSignal:refers_to_dosage :Dose9 ;
                    OpenPVSignal:refers_to_drug :finasteride ;
                    rdfs:label "usage for report 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#valproicAcid
:valproicAcid rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "N03AG01" ;
              rdfs:label "valproic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#warfarin
:warfarin rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "B01AA03" ;
          rdfs:label "warfarin" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#weightDecrease
:weightDecrease rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_MedDRA_code 10047895 ;
                OpenPVSignal:has_MedDRA_prefered_term "Weight decreased" ;
                rdfs:label "weight decrease" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#withdrawalSyndrome
:withdrawalSyndrome rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10048010 ;
                    OpenPVSignal:has_MedDRA_prefered_term "withdrawal syndrome" ;
                    rdfs:label "withdrawal syndrome" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#1_mg_dose
<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#1_mg_dose> rdf:type owl:NamedIndividual ,
                                                                                         OpenPVSignal:Dosage ;
                                                                                OpenPVSignal:refers_to_drug :finasteride ;
                                                                                OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
                                                                                OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                                                                                OpenPVSignal:has_value 1 ;
                                                                                OpenPVSignal:refers_to_dose_value "1 mg" ;
                                                                                rdfs:label "1 mg dose" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#5_mg_dose
<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#5_mg_dose> rdf:type owl:NamedIndividual ,
                                                                                         OpenPVSignal:Dosage ;
                                                                                OpenPVSignal:refers_to_drug :finasteride ;
                                                                                OpenPVSignal:refers_to_interval_between_administrations :one_day_interval ;
                                                                                OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                                                                                OpenPVSignal:has_value 5 ;
                                                                                OpenPVSignal:refers_to_dose_value "5 mg" ;
                                                                                rdfs:label "5 mg dose" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#PotentialMechanismOfFinasterideTriggeringconvulsions-thetestosterone/progesteroneParadigm
<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#PotentialMechanismOfFinasterideTriggeringconvulsions-thetestosterone/progesteroneParadigm> rdf:type owl:NamedIndividual ,
                                                                                                                                                                         OpenPVSignal:Adverse_Effect_Mechanism ;
                                                                                                                                                                OpenPVSignal:refers_to_adverse_effect :convulsions ;
                                                                                                                                                                mp:references :ref18 ;
                                                                                                                                                                OpenPVSignal:has_content "Additionally, progesterone acts as an anticonvulsant, while testosterone has pro-convulsant properties. An excess of testosterone brought about by finasteride treatment (through inhibition of the enzyme that converts it to 5a-DHT) results in a higher concentration of 17P-estradiol, a potent pro- convulsant hormone.18 " ;
                                                                                                                                                                rdfs:label "Potential mechanism of finasteride triggering convulsions-the testosterone/progesterone paradigm" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#convulsions/epilepticSeizuresPathobiology
<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#convulsions/epilepticSeizuresPathobiology> rdf:type owl:NamedIndividual ,
                                                                                                                         OpenPVSignal:Free_text_reporting_element ;
                                                                                                                OpenPVSignal:has_content """An epileptic seizure is defined as a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain.

Seizures can be generalized and concerning activity in both hemispheres; or partial, concerning a localized group of neurons. Partial seizures can further be defined as complex if consciousness is altered during an episode and simple if they do not affect memory and awareness. Seizures that can be attributed to an agent or underlying condition are considered symptomatic; seizures for which no underlying factor can be identified are considered unprovoked and attributable to epilepsy.
Symptomatic seizures can be induced by a multitude of factors including: stroke, head injury, anoxia, hypoglycaemia, infections, fever, menstruation, drugs and non-adherence to antiepileptic drugs. The incidence of acute symptomatic seizures is 29-39 per 100 000 per
year, while the incidence of single unprovoked seizures is 23-61 per 100,000 person-years.4
The incidence of drug-induced seizures is difficult to determine.5 Although numerous drugs
can induce a convulsive state or lower the seizure threshold, the most common classes of drug are central acting agents, anti-diabetics, sympathomimetics and anti-asthmatics""" ;
                                                                                                                rdfs:label "convulsions/epileptic seizures pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ergocalciferol/Ascorbicacid/folicacid/Thiaminehydrochloride/retinol/riboflavin/nicotiNicAcid
<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#ergocalciferol/Ascorbicacid/folicacid/Thiaminehydrochloride/retinol/riboflavin/nicotiNicAcid> rdf:type owl:NamedIndividual ,
                                                                                                                                                                            OpenPVSignal:Drug ;
                                                                                                                                                                   OpenPVSignal:has_ATC_code "A11CA01" ,
                                                                                                                                                                                             "A11CC01" ,
                                                                                                                                                                                             "A11DA01" ,
                                                                                                                                                                                             "A11GA01" ,
                                                                                                                                                                                             "A11HA04" ,
                                                                                                                                                                                             "B03BB01" ,
                                                                                                                                                                                             "C04AC01" ;
                                                                                                                                                                   rdfs:label "ergocalciferol/ ascorbic acid/folic acid/ thiamine hydrochloride/ retinol/riboflavin/nicotinic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#hydrochlorothiazide/Triamterene
<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#hydrochlorothiazide/Triamterene> rdf:type owl:NamedIndividual ,
                                                                                                               OpenPVSignal:Drug ;
                                                                                                      OpenPVSignal:has_ATC_code "C03EA01" ;
                                                                                                      rdfs:label "hydrochlorothiazide / triamterene" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#paracetamol/pseudoephedrine
<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#paracetamol/pseudoephedrine> rdf:type owl:NamedIndividual ,
                                                                                                           OpenPVSignal:Drug ;
                                                                                                  OpenPVSignal:has_ATC_code "N02BE01" ,
                                                                                                                            "R01BA52" ;
                                                                                                  rdfs:label "paracetamol / pseudoephedrine" .


###  http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithConfounders_drugsThatAreUsedAgainstconvulsions/seizures
<http://purl.org/OpenPVSignal/Signals/2014_4_finasterine_convulsions#reportsWithConfounders_drugsThatAreUsedAgainstconvulsions/seizures> rdf:type owl:NamedIndividual ,
                                                                                                                                                  OpenPVSignal:Reports_group ;
                                                                                                                                         OpenPVSignal:has_count 3 ;
                                                                                                                                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                         rdfs:label "reports with confounders (drugs that are used against convulsions/seizures" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
